EP Patent

EP2661435B1 — 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

Assigned to Janssen Pharmaceuticals Inc · Expires 2015-08-19 · 11y expired

What this patent protects

Patent listed against Hernexeos.

Drugs covered by this patent

Patent Metadata

Patent number
EP2661435B1
Jurisdiction
EP
Classification
—
Expires
2015-08-19
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.